Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial
Clinical trial NCT06992128 · RECRUITING
Trial details
- NCT number
- NCT06992128
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-22
- Primary completion
- 2028-01-31
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.